Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F McCormick

Showing results (291-300 of 375) with videos related to

Pageof 38
Sort By:
The Journal of Biological Chemistry|November 25, 1992
Interaction between the p21ras GTPase activating protein and the insulin receptorG J Pronk, R H Medema, B M Burgering, et al.
Science (New York, N.Y.)|July 13, 1990
Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene productM Frech, J John, V Pizon, et al.
Nature Medicine|June 1, 1997
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agentsC Heise, A Sampson-Johannes, A Williams, et al.
Science (New York, N.Y.)|October 4, 1985
A model for the tertiary structure of p21, the product of the ras oncogeneF McCormick, B F Clark, T F la Cour, et al.
Cureus|January 27, 2025
Knee Ligament Injuries in the National Football League: Impact of Field Surface Type During the 2020-2023 SeasonsWilliam F McCormick, Mitchell J Lomis, Christian B Cooper, et al.
Cancer Research|December 1, 1986
Detection of activated Mr 21,000 protein, the product of ras oncogenes, using antibodies with specificity for amino acid 12G Wong, N Arnheim, R Clark, et al.
Science (New York, N.Y.)|January 10, 1992
GAP domains responsible for ras p21-dependent inhibition of muscarinic atrial K+ channel currentsG A Martin, A Yatani, R Clark, et al.
Nature|August 23, 1990
Suppression of c-ras transformation by GTPase-activating proteinK Zhang, J E DeClue, W C Vass, et al.
Cancer Research|January 15, 1994
Analysis of the tumor suppressor activity of the K-rev-1 gene in human tumor cell linesK Y Sato, P G Polakis, H Haubruck, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1991
Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitorA M Pendergast, A J Muller, M H Havlik, et al.
Pageof 38

Showing results (291-300 of 375) with videos related to

Sort By:
Pageof 38
The Journal of Biological Chemistry|November 25, 1992
Interaction between the p21ras GTPase activating protein and the insulin receptorG J Pronk, R H Medema, B M Burgering, et al.
Science (New York, N.Y.)|July 13, 1990
Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene productM Frech, J John, V Pizon, et al.
Nature Medicine|June 1, 1997
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agentsC Heise, A Sampson-Johannes, A Williams, et al.
Science (New York, N.Y.)|October 4, 1985
A model for the tertiary structure of p21, the product of the ras oncogeneF McCormick, B F Clark, T F la Cour, et al.
Cureus|January 27, 2025
Knee Ligament Injuries in the National Football League: Impact of Field Surface Type During the 2020-2023 SeasonsWilliam F McCormick, Mitchell J Lomis, Christian B Cooper, et al.
Cancer Research|December 1, 1986
Detection of activated Mr 21,000 protein, the product of ras oncogenes, using antibodies with specificity for amino acid 12G Wong, N Arnheim, R Clark, et al.
Science (New York, N.Y.)|January 10, 1992
GAP domains responsible for ras p21-dependent inhibition of muscarinic atrial K+ channel currentsG A Martin, A Yatani, R Clark, et al.
Nature|August 23, 1990
Suppression of c-ras transformation by GTPase-activating proteinK Zhang, J E DeClue, W C Vass, et al.
Cancer Research|January 15, 1994
Analysis of the tumor suppressor activity of the K-rev-1 gene in human tumor cell linesK Y Sato, P G Polakis, H Haubruck, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1991
Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitorA M Pendergast, A J Muller, M H Havlik, et al.
Pageof 38